Amy Sheib

Amy S. Pasciak serves as a Contract Specialist at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), where she plays a pivotal role in executing complex acquisitions that support critical biomedical and behavioral research initiatives. She manages the full lifecycle of federal contracts, from requirements development and market research to solicitation, evaluation, award, and closeout, ensuring full compliance with the Federal Acquisition Regulation (FAR) and NIH-specific procurement policies. Her portfolio primarily encompasses research services, data systems, and technical infrastructure essential to advancing NIDA’s scientific mission, with a focus on high-complexity, mission-critical procurements that demand technical rigor and regulatory precision. While specific contractor names are not disclosed in available data, Pasciak’s contracting patterns reflect consistent engagement with a broad spectrum of vendors, including large prime contractors, mid-tier technical service providers, and small businesses capable of delivering specialized research support and IT solutions. Her working relationships are characterized by collaboration, transparency, and adherence to competitive procedures, fostering a fair and open marketplace aligned with federal procurement integrity standards. Pasciak’s set-aside preferences show a strong orientation toward open competition, with 93.2% of awards issued without set-aside restrictions. Nevertheless, she maintains a deliberate commitment to small business participation, with 6.8% of awards designated as Total Small Business Set-Asides under FAR 19.5, reflecting her alignment with federal goals to expand economic opportunity for small businesses without compromising mission needs. Her primary NAICS focus areas include 541712 (Research and Development in the Physical, Engineering, and Life Sciences), 541519 (Other Computer Related Services), and construction-related codes such as 237130 and 238210, indicating expertise in procuring scientific research services, software development, and specialized facility infrastructure. She routinely supports acquisitions involving data analytics, laboratory automation, and technical facilities modernization, demonstrating deep familiarity with the technical and operational demands of biomedical research environments.